Digital biomarkers for Alzheimer’s disease: the mobile/wearable devices opportunity

Digital biomarkers for Alzheimer’s disease: the mobile/wearable devices opportunity

Alzheimer’s Disease (AD) represents a major and rapidly growing burden to the healthcare ecosystem. A growing body of evidence indicates that cognitive, behavioral, sensory, and motor changes may precede clinical manifestations of AD by several years. Existing tests designed to diagnose neurodegenerative diseases, while well-validated, are often less effective […]